RESEARCH Open Access A Role For Human Brain Pericytes In .

3y ago
13 Views
3 Downloads
6.72 MB
20 Pages
Last View : 9d ago
Last Download : 3m ago
Upload by : Xander Jaffe
Transcription

Jansson et al. Journal of Neuroinflammation 2014, /1/104RESEARCHJOURNAL OFNEUROINFLAMMATIONOpen AccessA role for human brain pericytes inneuroinflammationDeidre Jansson1,2,4, Justin Rustenhoven1,4, Sheryl Feng1,2,4, Daniel Hurley5, Robyn L Oldfield6, Peter S Bergin4,7,Edward W Mee4,7, Richard LM Faull3,4 and Mike Dragunow1,2,4*AbstractBackground: Brain inflammation plays a key role in neurological disease. Although much research has beenconducted investigating inflammatory events in animal models, potential differences in human brain versusrodent models makes it imperative that we also study these phenomena in human cells and tissue.Methods: Primary human brain cell cultures were generated from biopsy tissue of patients undergoing surgeryfor drug-resistant epilepsy. Cells were treated with pro-inflammatory compounds IFNγ, TNFα, IL-1β, and LPS, andchemokines IP-10 and MCP-1 were measured by immunocytochemistry, western blot, and qRT-PCR. Microarrayanalysis was also performed on late passage cultures treated with vehicle or IFNγ and IL-1β.Results: Early passage human brain cell cultures were a mixture of microglia, astrocytes, fibroblasts and pericytes.Later passage cultures contained proliferating fibroblasts and pericytes only. Under basal culture conditions all celltypes showed cytoplasmic NFκB indicating that they were in a non-activated state. Expression of IP-10 and MCP-1were significantly increased in response to pro-inflammatory stimuli. The two chemokines were expressed in mixedcultures as well as cultures of fibroblasts and pericytes only. The expression of IP-10 and MCP-1 were regulated atthe mRNA and protein level, and both were secreted into cell culture media. NFκB nuclear translocation was alsodetected in response to pro-inflammatory cues (except IFNγ) in all cell types. Microarray analysis of brain pericytesalso revealed widespread changes in gene expression in response to the combination of IFNγ and IL-1β treatmentincluding interleukins, chemokines, cellular adhesion molecules and much more.Conclusions: Adult human brain cells are sensitive to cytokine challenge. As expected ‘classical’ brain immune cells,such as microglia and astrocytes, responded to cytokine challenge but of even more interest, brain pericytes alsoresponded to such challenge with a rich repertoire of gene expression. Immune activation of brain pericytes mayplay an important role in communicating inflammatory signals to and within the brain interior and may also beinvolved in blood brain barrier (BBB) disruption . Targeting brain pericytes, as well as microglia and astrocytes, mayprovide novel opportunities for reducing brain inflammation and maintaining BBB function and brain homeostasisin human brain disease.Keywords: Microglia, Astrocytes, Inflammation, Blood–brain barrier, Chemokines* Correspondence: m.dragunow@auckland.ac.nz1Department of Pharmacology and Clinical Pharmacology, The University ofAuckland, 85 Park Road, Auckland 1023, New Zealand2Gravida National Centre for Growth and Development, The University ofAuckland, Bldg 505, 85 Park Road, Auckland 1023, New ZealandFull list of author information is available at the end of the article 2014 Jansson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the CreativeCommons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly credited. The Creative Commons Public DomainDedication waiver ) applies to the data made available in this article,unless otherwise stated.

Jansson et al. Journal of Neuroinflammation 2014, /1/104IntroductionBrain inflammation occurs in a number of neurological(for example, epilepsy, Alzheimer’s disease, Parkinson’sdisease, motor neuron disease) and psychiatric (schizophrenia, depression) diseases and is generally thought to worsendisease symptoms and progression [1]. Although manydifferent brain cells are likely to be involved in brain inflammation, most attention has focused on the role of nonnerve brain cells, especially microglia and astrocytes [2-4].More recently, there has been an appreciation that perivascular cells may also be involved in brain inflammation. Inparticular, brain pericytes which surround endothelial cellsand are critical in the development and maintenance of theblood brain barrier (BBB) may be targets as well as effectorsof brain inflammatory processes [5,6]. Pericytes interact dynamically with astrocytes and microglia and can also receivesignals from the periphery resulting in central nervoussystem (CNS) inflammatory molecule production [7,8].CNS pericytes are also in a pivotal position to mediateinteractions between systemic and central brain inflammation [9] and have been shown to play a role in recruitmentof peripheral immune cells to the brain [10-12]. The further increase in brain infiltration of systemic immune molecules and cells as well as other blood components maydirectly cause neuronal damage and/or promote microglialinflammation [13].For the above reasons, targeting systemic and centralbrain inflammatory pathways for treating brain disordersis a high priority for neuropharmacological drug development. Most of this work has been undertaken usinganimal models and given potential species differencesmore work needs to be undertaken to identify pathwaysspecifically involved in human brain inflammation [14,15].In this regard, mixed in vitro cultures from adult humanbrain tissue have been characterized by several groups[16-18]. However, until recently, the exact composition ofthese cultures has been unclear. Previous work in ourgroup has revealed that a mixed population of astrocytes,microglia and fibroblast-like cells can be generated fromadult human brain cultures [17,19]. More recently, we andothers have identified a proportion of the fibroblast-likecells as human brain pericytes [5,19,20]. Many previousin vitro models of the BBB involve the use of animal ortransformed human pericytes and brain microvascularendothelial cells [21]. We sought to investigate the effectsof inflammatory molecules on primary adult humanbrain-derived cells (pericytes, astrocytes and microglia)that are in key locations for communicating inflammatorysignals to and within the brain.MethodsReagentsDMEM/F12, fetal bovine serum (FBS) and PenStrep glutamine (PSG) were obtained from Gibco/Life TechnologiesPage 2 of 20(Carlsbad, CA, USA). Other reagents included human recombinant IFNγ (R&D Systems, Minneapolis, MN, USA),IL-1β, TNFα (PeproTech, Rocky Hill, NJ, USA), Triton X-100, Tween 20, chloroform, lipopolysaccharide (LPS)and Hoechst 33528, and ExtrAvidin -peroxidase (Sigma,St. Louise, MO, USA), TRIzol (Ambion/Life Technologies,Carlsbad, CA, USA) and enhanced chemiluminescence(ECL) detection reagents (Amersham/GE Healthcare,Buckinghamshire, England).Biopsy brain tissueHuman middle temporal gyrus was obtained, with informed consent, from surgeries of patients with drug-resistant temporal lobe epilepsy, and with the approval of theNorthern Regional Ethics Committee (New Zealand).Isolation of mixed glial cultures from human brain tissueBrain tissue from the middle temporal gyrus (MTG),obtained following epilepsy surgery, was processed for theisolation and culture of microglia, astrocytes and brainpericytes, as previously described [19]. Cells were incubated at 37 C with 5% CO2 until seeding for experiments,approximately four to five days. Once mixed culturesreached the desired confluency, flasks were trypsinizedwith 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA)and scraped to obtain microglia and astrocytes. Cells wereseeded into 96-well plates at 5,000 cells/well in completemedia (DMEM/F12 with 10% FBS and 1% PSG (penicillin100 U/ml, streptomycin 100 μg/ml, L-glutamine 0.29mg/ml)) and were used for experiments one to three dayslater. Experiments performed on mixed glial cultures wereat passage 2 for all experiments in this study.For further culture of primary cells, cells from passage5 up to passage 9 were microglia- and astrocyte-freecultures and are referred to as pericytes throughout thetext [17]. These cells were kept in complete media andwere used directly or frozen in 5% dimethyl sulfoxide(DMSO), 95% FBS for later culture. Although many rodentstudies derive pericytes from isolated blood vessels, consistent with our work, human brain studies have generallyderived pericytes from dissociated grey matter [5,20].Leptomeningeal explant cultures were obtained byremoving meninges from MTG brain tissue and rinsingwith complete media. Meninges were cut into small pieces,2 to 3 mm2, and put into six-well plates containing 850 μlmedia/well, four to five pieces/well, and incubated at 37 C,5% CO2 in complete media. Tissue was cultured with suchlow volumes of media so that it would remain stationary inthe well. Media was changed after 48 to 72 hours in cultureand every three to four days afterwards. Depending oncases, normally around one to two weeks in culture, cellsbegan to migrate out from explants. After two to threeweeks in culture, explants were moved to a new six-wellplate to continue culture. Cells were generated from the

Jansson et al. Journal of Neuroinflammation 2014, /1/104explants again. This procedure was continued and explantswere moved once underlying cells became confluent.Cell treatmentsCells were treated for the indicated times with IFNγ,IL-1β and LPS, each at 10 ng/ml, TNFα at 50 ng/ml,unless otherwise stated, or vehicle (0.1% BSA in phosphatebuffered saline (PBS)).ImmunocytochemistryAt endpoint, cells were fixed using 4% paraformaldehydesolution. After washing in PBS with 0.2% Triton X-100 (PBS-T), plates were incubated with primary antibodiesovernight at 4 C (all antibodies were diluted in goatimmunobuffer (1% goat serum, 0.2% Triton X-100 , and0.04% thiomersal in PBS)). Dilutions of antibodies arelisted in Additional file 1: Table S1. Plates were washedagain in PBS-T and incubated with secondary antibodiestwo to three hours at room temperature, then rinsed.For fluorescent staining, nuclei were detected usingHoechst stains. Otherwise, plates were incubated withExtrAvidin-peroxidase diluted 1/500 in goat immunobuffer for one hour at room temperature then detectedusing 3,3’-diaminbenzidine. Discovery-1 Automated Fluorescence Microscope (Molecular Devices, Sunnyvale, CA,USA) or ImageXpress Micro XLS (Version 5.3.0.1,Molecular Devices) housed at the Biomedical ImagingResearch Unit, University of Auckland was used forimage acquisition from micro-well plates [22]. Quantitative analysis of positively stained cells and total cellswas performed using Metamorph software (Version 6.2.6,Molecular Devices) [23] using the Cell Scoring module forinterferon inducible protein 10 (IP-10) and monocytechemotactic protein-1 (MCP-1) expression or MetaXpress software (Version 5.3.0.1, Molecular Devices) for Multiwavelength Cell Scoring of co-labelling. Each conditionwas done in triplicate and four images/well were analyzed,with approximately 250 to 400 cells/field counted.Western blotAt endpoint, cells were rinsed with PBS and scraped intoEppendorf tubes. Cells were centrifuged and the pelletwas resuspended in lysis buffer (25 mM Tris–HCl pH7.5, 150 mM NaCl, 50 mM NaF, 0.5 mM EDTA pH 8,0.5% Triton-X 100 , 5 mM β-glycerophosphate, with fresh1 mM dithiothreitol (DTT), 1 mM phenylmethanesulfonylfluoride (PMSF), 1 mM Na3VO4). A total of 10 to 20 μgprotein diluted in Laemmli buffer (125 mM Tris–HCl, pH6.8, 5% glycerol, 4% sodium dodecyl sulfate (SDS), 0.2%bromophenol blue) was separated on 4% to 12% pre-castgels (Life Technologies) and separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Media samples forWestern blot were collected and centrifuged to removedebris. Supernatants were transferred to new tubes andPage 3 of 20diluted in Laemmli buffer and separated on SDS-PAGEas above.Fluorescent western blots were carried out as previouslydescribed [24]. Briefly, proteins were transferred to polyvinylidene difluoride (PVDF) membranes from Millipore(Billerica, MA, USA)(IPFL00010 Immobilon-FL 0.45 mm)for optimal fluorescence signal and blocked in OdysseyBlocking Buffer (Li-COR 927–40000) diluted 1:1 in Trisbuffered saline with 0.1% Tween -20 (TBS-T), for onehour at room temperature. Membranes were incubatedwith primary antibodies [see Additional file 1: Table S1]diluted in Odyssey Blocking Buffer and TBS-T (1:1) overnight at 4 C. Membranes were incubated with secondaryantibodies from Li-COR diluted in Odyssey and TBS-T(1:1) with 0.1% Tween -20 and 0.02% SDS for two hoursat room temperature. Images were captured using the LiCOR imaging system. Conversely, for chemiluminescentwestern blots the signal was detected using ECL detectionreagents (Amersham) and visualized using the Bio-RadChemiDoc imaging system.Quantitative RT-PCRQuantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was performed as described previously [19]. At endpoint, cells were rinsed 2 with PBSthen TRIzol (1 ml/well) was added and lysates weretransferred to screw cap tubes. Chloroform (200 μl) wasadded and tubes were shaken to mix. Samples were centrifuged, the aqueous layer was transferred to a new tubeand an equal volume of 70% ethanol (EtOH) was added.RNA was then extracted using RNeasy kits (Qiagen Inc.Venlo, Limburg, Nethlands). cDNA was made from 3μgDNase-1 (Promega, Madison, WI, USA) treated RNA usingthe Superscript III first strand synthesis kit (Invitrogen,Calrsbad, CA, USA). qRT-PCR was performed usingPlatinum SYBR Green qPCR SuperMix-UDG with Roxkit (Invitrogen). Standard curves were performed for allprimers used; sequences and efficiencies are included inAdditional file 2: Table S2. The level of gene expressionwas normalized to GAPDH at time zero or untreatedconditions using the ΔCt method [25].Microarray experimentFive cases from epilepsy tissue were chosen for this experiment, all male, with an average age of 45 / 7 years,with varying degrees of mesial temporal sclerosis. Allcultures were frozen down in 5% DMSO in FBS at passage3 or 4 after initial isolation. Cells were thawed from liquidnitrogen quickly at 37 C. Cells were transferred to 15 mlconicals with fresh pre-warmed complete DMEM/F12and centrifuged to pellet cells. Cells were resuspended in15 ml complete DMEM/F12 and transferred to T75 tissueculture flasks. Cells were incubated for three days to enable 80% to 90% confluency to be reached. Cells were

Jansson et al. Journal of Neuroinflammation 2014, /1/104trypsinized as indicated for human brain cell tissue cultureand seeded (passage 5) into six-well plates at 1.37 105cells/well in complete DMEM/F12 and incubated at 37 C,5% CO2 for two days. Cells were treated with vehicle(0.1% BSA in PBS) or IFNγ and IL-1β at a final concentration of 10 ng/ml for 24 hours, three wells of a six-wellplate per treatment per case. At endpoint, cells in six-wellplates were rinsed two times with PBS and lysed withTRIzol reagent. Triplicate wells were pooled and storedin screw cap tubes at 80 C until ready for RNA extraction. RNA extraction was carried out as above forqRT-PCR experiments. RNA quality was analyzed usingthe Experion System (BIO-RAD, Hercules, CA, USA)and the Experion RNA StdSens Analysis Kit. RNA wasthen labelled and hybridized to Affymetrix Genechip PrimeView Human Gene Expression Arrays (Santa Clara,CA, USA) according to the manufacturer’s instructions.Statistical analysisIndividual experiments were repeated at least three timeswith cells derived from separate cases. Each condition wasperformed in triplicate and mean / standard deviation ispresented from representative experiments. Statisticalanalysis was performed on replicates within experimentsusing one-way analysis of variance (ANOVA) and Dunnett’smultiple comparison tests for significance with GraphPadPrism analysis software.For the microarray analysis, PrimeView array data inCEL file format was read using the ‘affy’ package in thestatistical language R and normalized using the robustmulti-array (RMA) method. Quality assurance (QA) ofthe data showed that it was of good quality and free ofobvious artefacts or outliers. The ‘limma’ package wasused to compare differential expression between thecontrol (vehicle-treated) and IFNγ/IL-1β-treated samples.Benjamini-Hochberg false-discovery rate control was usedto adjust for multiple testing.ResultsComposition and inflammatory state of primary cells fromadult human brainImmunocytochemical analysis of dissociated cells fromMTG after two weeks in culture revealed a mixed population of cells (referred to from now on as ‘mixed glialcultures’). Positive staining for fibronectin and prolyl-4hydroxylase (P4H) (fibroblast markers), platelet-derivedgrowth factor receptor-beta (PDGFR-β), NG2 and alphasmooth muscle actin (αSMA) (pericyte markers), CD45(microglial cell marker), and glial fibrillary acidic protein(GFAP, astrocyte marker) was seen in early passages ofdissociated cultures (Figure 1A-G). No endothelial cellswere detected in any of our cultures using CD31 (datanot shown). Composition of the mixed glial culturesvaries from case to case, but we see 1-5% GFAP positivePage 4 of 20cells and 15% to 25% CD45 positive cells. In this initialculture, there are approximately 80% of cells that stainpositively for both αSMA and PDGFRβ (Figure 1H).After subsequent passaging, CD45 and GFAP positivecells were lost and only the proliferating fibroblast-likeand pericyte-like cells remained [26]. All cells in the latercultures are positive for fibronectin, and approximately90% of cells are positive for both αSMA and PDGFRβ(Figure 1H). For purposes of simplicity, late passage cultures will be referred to as pericytes for the remainder ofthe manuscript. Considering the expression of fibroblastand pericyte specific markers it is likely that these dividingunderlying cells derive from the meninges and brainmicrovasculature. To test this hypothesis, we resected theleptomeninges from the brain tissue and cultured themseparately from the MTG cells. These explants were ableto grow and divide in culture and generate new cells thatmigrate out of and away from the explant (unpublishedobservations). Positive staining for fibronectin, P4H, αSMAand PDGFR-β (Figure 2) was consistent with MTGcultures. Expression of both αSMA and PDGFR-β wereconfirmed in the MTG and explant cultures by westernblot analysis showing one specific band at the expectedmolecular weight [see Additional file 3: Figure S1]. TheNG2 antibody detected two bands which were expressedin both MTG and explant cultures [see Additional file 3:Figure S1].Translocation of nuclear factor light chain enhancer ofactivated B cells (NFκB) is often used as a marker of apro-inflammatory response. We examined NFκB p65 byimmunocytochemistry in the mixed glial cultures treatedwith either vehicle, IFNγ, TNFα, IL-1β, or LPS to inducea pro-inflammatory response. Positive staining for NFκBwas observed in the cytoplasm under control conditionsafter two hours of vehicle treatment. Treatment withTNFα, IL-1β or LPS induced translocation of NFκB tothe nucleus in CD45, GFAP and αSMA positive cells[see Additional files 4, 5, 6: Figures S2, S3 and S4 respectively]. This result indicates that under our standardbasal cell culture conditions adult human brain cellsare in a ‘resting’ non-immunologically-activated state,making them a powerful system for studying humanbrain inflammation.Combination of IFNγ and IL-1β/TNFα synergisticallyinduces IP-10 but not MCP-1 expression and secretion inmixed glial culturesPreviously, we have identified chemokines IP-10 andMCP-1 as being released into media from our mixedglial cu

RESEARCH Open Access A role for human brain pericytes in neuroinflammation Deidre Jansson1,2,4, Justin Rustenhoven1,4, Sheryl Feng1,2,4, Daniel Hurley5, Robyn L Oldfield6, Peter S Bergin4,7, Edward W Mee4,7, Richard LM Faull3,4 and Mike Dragunow1,2,4* Abstract Background: Brain inflammation plays a key role in neurological disease.

Related Documents:

COUNTY Archery Season Firearms Season Muzzleloader Season Lands Open Sept. 13 Sept.20 Sept. 27 Oct. 4 Oct. 11 Oct. 18 Oct. 25 Nov. 1 Nov. 8 Nov. 15 Nov. 22 Jan. 3 Jan. 10 Jan. 17 Jan. 24 Nov. 15 (jJr. Hunt) Nov. 29 Dec. 6 Jan. 10 Dec. 20 Dec. 27 ALLEGANY Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open .

Keywords: Open access, open educational resources, open education, open and distance learning, open access publishing and licensing, digital scholarship 1. Introducing Open Access and our investigation The movement of Open Access is attempting to reach a global audience of students and staff on campus and in open and distance learning environments.

Network Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Contract code 3UWH 3UWF 3UWD 3UWB 3UW9 3UW7 3UW5 Deductible1 (individual/family) 1,500/ 3,000 1,750/ 3,500 2,000/ 4,000 2,250/ 4,500 2,500/ 5,000 2,750/ 5,500 3,000/ 6,000

akuntansi musyarakah (sak no 106) Ayat tentang Musyarakah (Q.S. 39; 29) لًََّز ãَ åِاَ óِ îَخظَْ ó Þَْ ë Þٍجُزَِ ß ا äًَّ àَط لًَّجُرَ íَ åَ îظُِ Ûاَش

Collectively make tawbah to Allāh S so that you may acquire falāḥ [of this world and the Hereafter]. (24:31) The one who repents also becomes the beloved of Allāh S, Âَْ Èِﺑاﻮَّﺘﻟاَّﺐُّ ßُِ çﻪَّٰﻠﻟانَّاِ Verily, Allāh S loves those who are most repenting. (2:22

What is Open Science? § Open Access to articles and lab notebooks § Open Data § Open Source Code § Open Collaboration (e.g., citizen science) § Open Technology (e.g., Makers) § Open Funding OECD (2015), "Making Open Science a Reality", OECD Science, Technology and Industry Policy Papers, No. 25, OECD Publishing,

after open embolectomy procedures versus using it on selective basis with regards to the outcomes in the management of acute lower limb ischemia. A n g i o l o g y :O pe n A c c e s s ISSN: 2329-9495 Angiology: Open Access Elshafei et al., Angiol 2018, 6:4 DOI: 10.4172/2329-9495.1000219 Research Article Open Access Angiol, an open access .

2.1 ASTM Standards: C 230 Specification for Flow Table for Use in Tests of Hydraulic Cement3 C 305 Practice for Mechanical Mixing of Hydraulic Cement Pastes and Mortars of Plastic Consistency3 C 349 Test Method for Compressive Strength of Hydraulic Cement Mortars (Using Portions of Prisms Broken in Flexure)3 C 511 Specification for Moist Cabinets, Moist Rooms and Water Storage Tanks Used in .